In 190 patients who had curative liver surgery for colorectal metastases, KRAS mutations (37.9% of patients) were associated with significantly worse overall and recurrence-free survival and more aggressive recurrence patterns. (Surgery Today)
KRAS Mutations Predict Worse Outcomes After Liver Metastasis Surgery
The CRC Digest